Advances in the management of intracerebral hemorrhage (Q37793839)

23 August 2017

Advances in the management of intracerebral hemorrhage (English)

1 reference

23 August 2017

Opeolu Adeoye

1

1 reference

23 August 2017

Joseph P Broderick

series ordinal

2

1 reference

23 August 2017

language of work or name

English

0 references

publication date

28 September 2010

1 reference

23 August 2017

Nature Reviews Neurology

1 reference

23 August 2017

6

1 reference

23 August 2017

11

1 reference

23 August 2017

593-601

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneurol.2010.146

23 August 2017

0 references

cites work

Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. International Stroke Incidence Collaboration.

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Early hemorrhage growth in patients with intracerebral hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Progression of mass effect after intracerebral hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Rebleeding leads to poor outcome in ultra-early craniotomy for intracerebral hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Early neurologic deterioration in intracerebral hemorrhage: predictors and associated factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Intracerebral haemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care a

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Long-term mortality after intracerebral hemorrhage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Long term survival after primary intracerebral haemorrhage: a retrospective population based study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Update on medical and surgical management of intracerebral hemorrhage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Cost-effectiveness of recombinant activated factor VII in the treatment of intracerebral hemorrhage.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Risk factors for intracerebral hemorrhage in the general population: a systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

The incidence of deep and lobar intracerebral hemorrhage in whites, blacks, and Hispanics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Is hypertension a more frequent risk factor for deep than for lobar supratentorial intracerebral haemorrhage?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Trends in the incidence, mortality, and survival rate of cardiovascular disease in a Japanese community: the Hisayama study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Incidence and trends of stroke and its subtypes in China: results from three large cities

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Location and outcome of anticoagulant-associated intracerebral hemorrhage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Warfarin use leads to larger intracerebral hematomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

The increasing incidence of anticoagulant-associated intracerebral hemorrhage.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Apolipoprotein E genotype and cerebral amyloid angiopathy-related hemorrhage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Effects of perindopril-based lowering of blood pressure on intracerebral hemorrhage related to amyloid angiopathy: the PROGRESS trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Lateral displacement of the brain and level of consciousness in patients with an acute hemispheral mass.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Recombinant activated factor VII for acute intracerebral hemorrhage.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Intraventricular hemorrhage: Anatomic relationships and clinical implications.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Intraventricular hemorrhage and hydrocephalus after spontaneous intracerebral hemorrhage: results from the STICH trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage: risk factors, clinical impact, and effect of hemostatic therapy with recombinant activated factor VII.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Relative edema volume is a predictor of outcome in patients with hyperacute spontaneous intracerebral hemorrhage.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Significance of perihematomal edema in acute intracerebral hemorrhage: the INTERACT trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Edema after intracerebral hemorrhage: correlations with coagulation parameters and treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Mechanisms of brain injury after intracerebral haemorrhage.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Safety and tolerability of NXY-059 for acute intracerebral hemorrhage: the CHANT Trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Gavestinel does not improve outcome after acute intracerebral hemorrhage: an analysis from the GAIN International and GAIN Americas studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Can a subset of intracerebral hemorrhage patients benefit from hemostatic therapy with recombinant activated factor VII?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Thromboembolic events with recombinant activated factor VII in spontaneous intracerebral hemorrhage: results from the Factor Seven for Acute Hemorrhagic Stroke (FAST) trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Contrast extravasation on CT angiography predicts hematoma expansion in intracerebral hemorrhage.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

CT angiography "spot sign" predicts hematoma expansion in acute intracerebral hemorrhage.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Vascular and nonvascular mimics of the CT angiography "spot sign" in patients with secondary intracerebral hemorrhage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Transcranial duplex sonography for monitoring hyperacute intracerebral hemorrhage.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Molecular signatures of vascular injury are associated with early growth of intracerebral hemorrhage.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Serum glial fibrillary acidic protein as a biomarker for intracerebral haemorrhage in patients with acute stroke

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Clinical usefulness of a biomarker-based diagnostic test for acute stroke: the Biomarker Rapid Assessment in Ischemic Injury (BRAIN) study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Explorative investigation of biomarkers of brain damage and coagulation system activation in clinical stroke differentiation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Timing of fresh frozen plasma administration and rapid correction of coagulopathy in warfarin-related intracerebral hemorrhage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Urgent reversal of warfarin with prothrombin complex concentrate.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Recombinant factor VIIa for rapid reversal of warfarin anticoagulation in acute intracranial hemorrhage.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Use of recombinant factor VIIa in patients with warfarin-associated intracranial hemorrhage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Blood pressure and clinical outcomes in the International Stroke Trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

U-shaped relationship between mortality and admission blood pressure in patients with acute stroke

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Rate of 24-hour blood pressure decline and mortality after spontaneous intracerebral hemorrhage: a retrospective analysis with a random effects regression model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Antihypertensive treatment of acute cerebral hemorrhage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Efficiency of citicoline in increasing muscular strength of patients with nontraumatic cerebral hemorrhage: a double-blind randomized clinical trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Citicoline in intracerebral haemorrhage: a double-blind, randomized, placebo-controlled, multi-centre pilot study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Surgical management and case-fatality rates of intracerebral hemorrhage in 1988 and 2005

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Primary intracerebral hemorrhage in Izumo City, Japan: incidence rates and outcome in relation to the site of hemorrhage.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Surgery for spontaneous intracerebral hemorrhage has greater remedial value than conservative therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Recommendations for the Management of Intracranial Haemorrhage – Part I: Spontaneous Intracerebral Haemorrhage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Minimally Invasive Craniopuncture Therapy vs. Conservative Treatment for Spontaneous Intracerebral Hemorrhage: Results from a Randomized Clinical Trial in China

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Endoscopic surgery versus medical treatment for spontaneous intracerebral hematoma: a randomized study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Stereotactic treatment of intracerebral hematoma by means of a plasminogen activator: a multicenter randomized controlled trial (SICHPA).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Frameless stereotactic aspiration and thrombolysis of deep intracerebral hemorrhage is associated with reduction of hemorrhage volume and neurological improvement

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Preliminary findings of the minimally-invasive surgery plus rtPA for intracerebral hemorrhage evacuation (MISTIE) clinical trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Intraventricular thrombolysis speeds blood clot resolution: results of a pilot, prospective, randomized, double-blind, controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Early surgical treatment for supratentorial intracerebral hemorrhage: a randomized feasibility study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Image-guided endoscopic evacuation of spontaneous intracerebral hemorrhage.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Recombinant activated factor VII for acute intracerebral hemorrhage: US phase IIA trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Mannitol in intracerebral hemorrhage: a randomized controlled study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2010.146

Preliminary report of the clot lysis evaluating accelerated resolution of intraventricular hemorrhage (CLEAR-IVH) clinical trial.

31 March 2020

1 reference

12 December 2020

Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis

1 reference

12 December 2020

Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

1 reference

12 December 2020

Management of intracerebral hemorrhage in a large metropolitan population

1 reference

12 December 2020

Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association

1 reference

12 December 2020

10.1038/NRNEUROL.2010.146

Identifiers

DOI

1 reference

Dimensions Publication ID

23 August 2017

0 references

1 reference